The interaction of T lymphocytes with
tumor cells, a key step in the antitumor immune response, is suppressed by
adenosine, a
nucleoside produced at increased levels within the hypoxic
tumor environment. We have explored the mechanism by which
adenosine interferes with the lymphocyte:
tumor cell interaction. The adhesion of anti-CD3-stimulated T cells to syngeneic MCA-38 mouse
colon adenocarcinoma cells did not involve
LFA-1 (alpha(L)beta(2)) or
VLA-5 (alpha(5)beta(1)). However,
antibodies against either lymphocyte alpha(4) or beta(7) (but not beta(1))
integrin subunits, or against
VCAM-1 on the
tumor cells, significantly suppressed adhesion, showing that the recognition of MCA-38 cells by T cells is strongly dependent upon the association of alpha(4)beta(7) on the effector cells with
VCAM-1 on the
tumor targets. This association is modulated by
adenosine: The ability of
adenosine to suppress T cell adhesion to MCA-38 cells was lost if alpha(4)beta(7) was functionally blocked with anti-alpha(4)
antibodies (i) prior to or (ii) during the adhesion assay or if (iii) alpha(+)(4) cells were depleted from the T lymphocyte population. The binding of T cells to
fibronectin through alpha(4)beta(1) was not suppressed by
adenosine. We conclude that
adenosine partially inhibits the interaction of T lymphocytes with
tumor cells by blocking the function of
integrin alpha(4)beta(7).